The CDC Cancer Genomics Program: Translating Research into Public Health Practice

The CDC Division of Cancer Prevention and Control (DCPC) announces the availability of Fiscal Year 2019 funds to implement DP19-1905, The CDC Cancer Genomics Program: Translating Research into Public Health Practice. This program addresses the utilization of cancer genetic services as a strategy for cancer prevention and control. The primary outcomes of this NOFO are to increase screening of cancer family history and to increase the use of genetic counseling and testing for hereditary cancer syndromes, specifically Hereditary Breast and Ovarian Cancer (HBOC) Syndrome and Lynch Syndrome (LS), among individuals meeting recommendations for referral. This funding opportunity supports the implementation and evaluation of public health activities within four strategies to build the evidence base and disseminate best practices. These priorities will be accomplished by funding up to five recipients to develop, implement, and evaluate state-level programs in cancer genomics. Funding will support applicants to: Increase organizational capacity to address public health priorities in cancer genomics Expand and develop surveillance systems to measure the hereditary cancer burden Educate the public on family cancer history as a risk factor for cancer Educate providers about family history screening and referring patients to cancer genetic services Develop partnerships to facilitate policy and systems changes that increase access to and use of cancer genetic services